Repros Therapeutics Inc.
RPRX
RPRX was delisted on the 31st of January, 2018.
64 hedge funds and large institutions have $106M invested in Repros Therapeutics Inc. in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 25 closing their positions.
7% more call options, than puts
Call options by funds: $3.18M | Put options by funds: $2.96M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.56% less ownership
Funds ownership: 64.81% → 61.25% (-3.6%)
11% less funds holding
Funds holding: 72 → 64 (-8)
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
30% less capital inflows, than outflows
Capital inflows: $17.6M | Capital outflows: $25M
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.87M |
| 2 |
Renaissance Technologies
New York
|
+$1.57M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.22M |
| 4 |
Morgan Stanley
New York
|
+$1.15M |
| 5 |
Millennium Management
New York
|
+$775K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock Fund Advisors
San Francisco,
California
|
-$4.91M |
| 2 |
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
-$3.58M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.64M |
| 4 |
SAM
Senzar Asset Management
New York
|
-$2.1M |
| 5 |
Farallon Capital Management
San Francisco,
California
|
-$1.72M |
RPRX Hedge Fund Activity: Q2 2015 in Review
64 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q2 2015, worth a combined $106M — down 21% from $135M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of RPRX and 17 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 16 added.
The largest buyer was Fidelity Investments, adding an estimated $3.87M. The largest seller was BlackRock Fund Advisors, cutting an estimated $4.91M.
- 64 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q2 2015, down from 72 in Q1 2015.
- Funds reported $106M of Repros Therapeutics Inc. stock for Q2 2015, down 21% quarter-over-quarter.
- 17 funds opened new Repros Therapeutics Inc. positions in Q2 2015 and 25 closed out, a net change of -8 holders.
- The largest Repros Therapeutics Inc. buyer in Q2 2015 was Fidelity Investments, an estimated $3.87M added.
- The largest Repros Therapeutics Inc. seller in Q2 2015 was BlackRock Fund Advisors, an estimated $4.91M sold.
Based on aggregated 13F filings for Q2 2015.